Stock Market & Financial Investment News

News Breaks January 29, 2013 09:20 EDT SNY, ISIS FDA PDUFA Date for Genzyme and Isis Pharmaceuticals' Kynamro The FDA assigned a Prescription Drug User Fee Act (PDUFA) action date for the review of Genzyme, a Sanofi company, and Isis Pharmaceuticals' Kynamro, for treatment of patients with homozygous familial hypercholesterolemia, of January 29, 2013. News For SNY;ISIS From The Last 14 Days Check below for free stories on SNY;ISIS the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 21, 2013 07:44 EDT SNY Sachs Associates to host a forum Subscribe for More Information May 20, 2013 17:26 EDT SNY Regeneron, Genentech, Sanofi enter into 'Zaltrap agreement' Subscribe for More Information 11:27 EDT SNY Appeals court reverses, remands patent ruling in Sanofi suit against Mylan, Teva Subscribe for More Information 07:34 EDT ISIS UBS to host a conference Subscribe for More Information May 17, 2013 08:03 EDT SNY Sanofi reports positive topline results from pivotal Phase III Jakarta study Subscribe for More Information 05:18 EDT SNY Sanofi says JAK2 inhibitor for myelofibrosis met primary endpoint Subscribe for More Information May 15, 2013 15:16 EDT SNY Sanofi systemic sclerosis treatment designated for orphan drug status Subscribe for More Information 05:39 EDT SNY Sanofi, Regeneron announce patient enrollment in two Phase 3 trials Subscribe for More Information May 13, 2013 09:44 EDT SNY Several companies reportedly interested in buying Adcock Ingram, Globes says Subscribe for More Information 07:30 EDT SNY TechConnect to host a summit 2013 National Innovation Summit is being held in Washington, D.C. on May 12-16. May 10, 2013 11:48 EDT SNY Drugmakers to face pressure on U.S. prices, Reuters says Subscribe for More Information May 9, 2013 16:59 EDT ISIS Isis Pharmaceuticals earns $3.5M from Biogen Subscribe for More Information 11:15 EDT ISIS High option volume stocks: BKS ISIS BRY GMCR JOE 06:16 EDT ISIS Isis Pharmaceuticals 9M share Secondary priced at $19.00 Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.